BioTime Subsidiary Asterias Biotherapeutics Announces Investment by CEO

ALAMEDA, Calif. & MENLO PARK, Calif.-- -- BioTime , Inc. today announced that on June 12, 2014, Pedro Lichtinger, President and Chief Executive Officer of its subsidiary Asterias Biotherapeutics , Inc. purchased from Asterias 200,000 shares of Asterias Series B common stock at a price of $2.34 per share.

http://ift.tt/1pcpzJi